Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats.

Bussi S, Maisano F, Tedoldi F, Kirchin MA.

Pediatr Radiol. 2019 Jul;49(8):1110-1111. doi: 10.1007/s00247-019-04439-9. Epub 2019 Jun 28. No abstract available.

PMID:
31254022
2.

Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance®) to neonatal and juvenile rats.

Bussi S, Penard L, Bonafè R, Botteron C, Celeste R, Coppo A, Queliti R, Kirchin MA, Tedoldi F, Maisano F.

Regul Toxicol Pharmacol. 2018 Feb;92:268-277. doi: 10.1016/j.yrtph.2017.12.016. Epub 2017 Dec 24.

3.

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.

Bussi S, Coppo A, Botteron C, Fraimbault V, Fanizzi A, De Laurentiis E, Colombo Serra S, Kirchin MA, Tedoldi F, Maisano F.

J Magn Reson Imaging. 2018 Mar;47(3):746-752. doi: 10.1002/jmri.25822. Epub 2017 Jul 21.

4.

Low radiation dose in computed tomography: the role of iodine.

Aschoff AJ, Catalano C, Kirchin MA, Krix M, Albrecht T.

Br J Radiol. 2017 Aug;90(1076):20170079. doi: 10.1259/bjr.20170079. Epub 2017 May 4. Review.

5.

Reply.

Spinazzi A, Pirovano G, Shen N, Kirchin MA.

AJNR Am J Neuroradiol. 2016 Mar;37(3):E22-4. doi: 10.3174/ajnr.A4707. Epub 2016 Jan 14. No abstract available.

6.

Development of a New Imaging Bulk Package for Multipatient Use in MDCT.

Spinazzi A, Marchildon PA, Murray EA, Giorgi M, Kirchin MA, Sireci SN.

AJR Am J Roentgenol. 2015 Oct;205(4):697-702. doi: 10.2214/AJR.14.14162.

PMID:
26397317
7.

Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.

Soulez G, Bloomgarden DC, Rofsky NM, Smith MP, Abujudeh HH, Morgan DE, Lichtenstein RJ, Schiebler ML, Wippold FJ 2nd, Russo C, Kuhn MJ, Mennitt KW, Maki JH, Stolpen A, Liou J, Semelka RC, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.

PMID:
26295633
8.

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).

Vaneckova M, Herman M, Smith MP, Mechl M, Maravilla KR, Weichet J, Spampinato MV, Žižka J, Wippold FJ 2nd, Baima JJ, Babbel R, Bültmann E, Huang RY, Buhk JH, Bonafé A, Colosimo C, Lui S, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16.

9.

Evaluation of image quality, radiation dose and diagnostic performance of dual-energy CT datasets in patients with hepatocellular carcinoma.

Anzidei M, Di Martino M, Sacconi B, Saba L, Boni F, Zaccagna F, Geiger D, Kirchin MA, Napoli A, Bezzi M, Catalano C.

Clin Radiol. 2015 Sep;70(9):966-73. doi: 10.1016/j.crad.2015.05.003. Epub 2015 Jun 19.

PMID:
26095726
10.

Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.

Schneider G, Probst T, Kirchin MA, Stroeder J, Fries P, Buecker A.

Radiol Med. 2015 Dec;120(12):1100-11. doi: 10.1007/s11547-015-0548-7. Epub 2015 Jun 19.

12.

Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).

Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Žižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G.

AJNR Am J Neuroradiol. 2015 Jan;36(1):14-23. doi: 10.3174/ajnr.A4154. Epub 2014 Oct 9.

13.

Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?

Xing X, Zeng X, Li X, Zhao Q, Kirchin MA, Pirovano G, Wang X, Li Y, Iezzi R, De Cobelli F.

Radiol Med. 2015 Feb;120(2):239-50. doi: 10.1007/s11547-014-0434-8. Epub 2014 Sep 3.

PMID:
25183340
14.

Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system.

Pirovano G, Kirchin MA, Lorusso V, Patel R, Shen N.

J Magn Reson Imaging. 2015 Apr;41(4):1096-103. doi: 10.1002/jmri.24653. Epub 2014 May 8.

PMID:
24807269
15.

Comparison of 3D TOF-MRA and 3D CE-MRA at 3T for imaging of intracranial aneurysms.

Cirillo M, Scomazzoni F, Cirillo L, Cadioli M, Simionato F, Iadanza A, Kirchin M, Righi C, Anzalone N.

Eur J Radiol. 2013 Dec;82(12):e853-9. doi: 10.1016/j.ejrad.2013.08.052. Epub 2013 Sep 12.

PMID:
24103356
16.

Lowering radiation exposure in CT angiography using automated tube potential selection and optimized iodine delivery rate.

Schwarz F, Grandl K, Arnoldi A, Kirchin MA, Bamberg F, Reiser MF, Becker CR.

AJR Am J Roentgenol. 2013 Jun;200(6):W628-34. doi: 10.2214/AJR.12.9635.

PMID:
23701094
17.

Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.

Schneider G, Schürholz H, Kirchin MA, Bücker A, Fries P.

Pediatr Radiol. 2013 Jan;43(2):202-11. doi: 10.1007/s00247-012-2498-8. Epub 2012 Nov 24.

PMID:
23179483
18.

Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.

Johansson L, Kirchin MA, Ahlström H.

Acta Radiol. 2012 Dec 1;53(10):1112-7. doi: 10.1258/ar.2012.120181. Epub 2012 Oct 18.

PMID:
23081961
19.

Dual-Source computed tomography of the chest in the surgical planning of repeated cardiac surgery.

Nikolaou K, Vicol C, Vogt F, Kirchin M, Saam T, Müller-Starck J, Reiser MF, Rist C.

J Cardiovasc Surg (Torino). 2012 Apr;53(2):247-55.

PMID:
22456649
20.

Low-dose multidetector CT angiography in the evaluation of infrarenal aorta and peripheral arterial occlusive disease.

Iezzi R, Santoro M, Marano R, Di Stasi C, Dattesi R, Kirchin M, Tinelli G, Snider F, Bonomo L.

Radiology. 2012 Apr;263(1):287-98. doi: 10.1148/radiol.11110700. Epub 2012 Feb 13.

PMID:
22332067
21.

Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.

Pediconi F, Miglio E, Telesca M, Luciani ML, Kirchin MA, Passariello R, Catalano C.

Invest Radiol. 2012 Feb;47(2):128-35. doi: 10.1097/RLI.0b013e318230061c.

PMID:
21934515
22.

Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.

Neira C, Anzidei M, Napoli A, Kirchin MA, Cavallo Marincola B, Zaccagna F, Catalano C, Passariello R, Tedoldi F.

Invest Radiol. 2011 Dec;46(12):774-82. doi: 10.1097/RLI.0b013e318227c57c.

PMID:
21730871
23.

Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects.

Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R.

Br J Radiol. 2011 Aug;84(1004):677-90. doi: 10.1259/bjr/20673379. Epub 2011 May 17. Review.

24.

First-pass and high-resolution steady-state magnetic resonance angiography of the peripheral arteries with gadobenate dimeglumine: an assessment of feasibility and diagnostic performance.

Anzidei M, Napoli A, Zaccagna F, Cavallo Marincola B, Zini C, Kirchin MA, Catalano C, Passariello R.

Invest Radiol. 2011 May;46(5):307-16. doi: 10.1097/RLI.0b013e3182021879.

PMID:
21317793
25.

Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.

Morana G, Grazioli L, Kirchin MA, Bondioni MP, Faccioli N, Guarise A, Schneider G.

Invest Radiol. 2011 Apr;46(4):225-39. doi: 10.1097/RLI.0b013e3181feee3a.

PMID:
21102346
26.

Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.

Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.

Radiology. 2010 Dec;257(3):653-61. doi: 10.1148/radiol.10100732. Epub 2010 Sep 30.

PMID:
20884914
27.

Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.

Giesel FL, Runge V, Kirchin M, Mehndiratta A, Gerigk L, Corell B, von Gall C, Kauczor HU, Essig M.

J Comput Assist Tomogr. 2010 Sep-Oct;34(5):678-83. doi: 10.1097/RCT.0b013e3181e359c2.

PMID:
20861769
28.

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.

Gerretsen SC, le Maire TF, Miller S, Thurnher SA, Herborn CU, Michaely HJ, Kramer H, Vanzulli A, Vymazal J, Wasser MN, Ballarati CE, Kirchin MA, Pirovano G, Leiner T.

Radiology. 2010 Jun;255(3):988-1000. doi: 10.1148/radiol.10090357.

PMID:
20501735
29.

Dynamic susceptibility contrast-enhanced MRI evaluation of cerebral intraventricular tumors: preliminary results.

Holveck A, Grand S, Boini S, Kirchin M, Le Bas JF, Dietemann JL, Bracard S, Kremer S.

J Neuroradiol. 2010 Dec;37(5):269-75. doi: 10.1016/j.neurad.2009.11.001.

PMID:
20435349
30.

Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.

Grazioli L, Bondioni MP, Faccioli N, Gambarini S, Tinti R, Schneider G, Kirchin M.

J Gastrointest Cancer. 2010 Dec;41(4):221-32. doi: 10.1007/s12029-010-9145-0.

PMID:
20405242
31.

High-resolution steady state magnetic resonance angiography of the carotid arteries: are intravascular agents necessary?: feasibility and preliminary experience with gadobenate dimeglumine.

Anzidei M, Napoli A, Marincola BC, Kirchin MA, Neira C, Geiger D, Zaccagna F, Catalano C, Passariello R.

Invest Radiol. 2009 Dec;44(12):784-92. doi: 10.1097/RLI.0b013e3181bfe38a.

PMID:
19858728
32.

Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.

Iezzi R, Soulez G, Thurnher S, Schneider G, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

Eur J Radiol. 2011 Feb;77(2):358-68. doi: 10.1016/j.ejrad.2009.07.020. Epub 2009 Aug 12.

PMID:
19679417
33.

The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.

Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R.

Invest Radiol. 2009 Jul;44(7):412-21. doi: 10.1097/RLI.0b013e3181a53654.

PMID:
19448554
34.

Nephrogenic systemic fibrosis: the need for accurate case reporting.

Spinazzi A, Kirchin MA, Pirovano G.

J Magn Reson Imaging. 2009 May;29(5):1240; author reply 1241. doi: 10.1002/jmri.21741. No abstract available.

PMID:
19388104
35.
36.

Imaging coronary and extracoronary atherosclerosis: feasibility and impact of whole-body computed tomography angiography.

Napoli A, Catalano C, Francone M, Sciacca V, Carbone I, Greco C, Anzidei M, Calabrese FA, Marincola BC, Kirchin MA, Vestri A, Arca M, Iuliano L, Passariello R.

Eur Radiol. 2009 Jul;19(7):1704-14. doi: 10.1007/s00330-009-1342-5. Epub 2009 Mar 11.

PMID:
19277677
37.

Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.

Calabrese M, Brizzi D, Carbonaro L, Chiaramondia M, Kirchin MA, Sardanelli F.

Radiol Med. 2009 Mar;114(2):267-85. doi: 10.1007/s11547-008-0358-2. Epub 2009 Feb 4. English, Italian.

PMID:
19194774
38.

Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.

Pediconi F, Catalano C, Padula S, Roselli A, Dominelli V, Cagioli S, Kirchin MA, Pirovano G, Passariello R.

AJR Am J Roentgenol. 2008 Nov;191(5):1339-46. doi: 10.2214/AJR.07.3533.

PMID:
18941066
39.

Magnetic resonance imaging of the spine at 3 Tesla.

Fries P, Runge VM, Kirchin MA, Watkins DM, Buecker A, Schneider G.

Semin Musculoskelet Radiol. 2008 Sep;12(3):238-52. doi: 10.1055/s-0028-1083107. Epub 2008 Oct 10. Review.

PMID:
18850504
40.

Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.

Bueltmann E, Erb G, Kirchin MA, Klose U, Naegele T.

Invest Radiol. 2008 Oct;43(10):695-702. doi: 10.1097/RLI.0b013e31817d1505.

PMID:
18791411
41.
42.

Follow-up of coiled cerebral aneurysms at 3T: comparison of 3D time-of-flight MR angiography and contrast-enhanced MR angiography.

Anzalone N, Scomazzoni F, Cirillo M, Righi C, Simionato F, Cadioli M, Iadanza A, Kirchin MA, Scotti G.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1530-6. doi: 10.3174/ajnr.A1166. Epub 2008 Jun 12.

43.

Renal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography--comparison with DSA.

Soulez G, Pasowicz M, Benea G, Grazioli L, Niedmann JP, Konopka M, Douek PC, Morana G, Schaefer FK, Vanzulli A, Bluemke DA, Maki JH, Prince MR, Schneider G, Ballarati C, Coulden R, Wasser MN, McCauley TR, Kirchin MA, Pirovano G.

Radiology. 2008 Apr;247(1):273-85. doi: 10.1148/radiol.2471070711. Epub 2008 Feb 7.

PMID:
18372471
44.

MR angiography for detection of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.

Schneider G, Uder M, Koehler M, Kirchin MA, Massmann A, Buecker A, Geisthoff U.

AJR Am J Roentgenol. 2008 Apr;190(4):892-901. doi: 10.2214/AJR.07.2966.

PMID:
18356434
45.

Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.

Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA.

Invest Radiol. 2008 Apr;43(4):236-42. doi: 10.1097/RLI.0b013e318160678d.

PMID:
18340247
46.

Optimization of cardiac MSCT contrast injection protocols: dependency of the main bolus contrast density on test bolus parameters and patients' body weight.

Rist C, Becker CR, Kirchin MA, Johnson TR, Busch S, Bae KT, Leber AW, Reiser MF, Nikolaou K.

Acad Radiol. 2008 Jan;15(1):49-57.

PMID:
18078906
47.

Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.

Picozzi P, Kirchin MA.

Neuroradiology. 2007 Jul;49 Suppl 1:S27-34. Review.

PMID:
17665155
48.

Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial.

Thurnher S, Miller S, Schneider G, Ballarati C, Bongartz G, Herborn CU, Schoenberg S, Cova MA, Morana G, Niazi K, Iezzi R, Taupitz M, Bluemke DA, Kreitner KF, Kirchin MA, Pirovano G.

AJR Am J Roentgenol. 2007 Nov;189(5):1223-37.

PMID:
17954665
49.

Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography.

Cademartiri F, Maffei E, Palumbo AA, Malagò R, La Grutta L, Meiijboom WB, Aldrovandi A, Fusaro M, Vignali L, Menozzi A, Brambilla V, Coruzzi P, Midiri M, Kirchin MA, Mollet NR, Krestin GP.

Eur Radiol. 2008 Mar;18(3):576-83. Epub 2007 Oct 13.

PMID:
17934740
50.

Non-invasive evaluation of coronary artery stent patency with retrospectively ECG-gated 64-slice CT angiography.

Carbone I, Francone M, Algeri E, Granatelli A, Napoli A, Kirchin MA, Catalano C, Passariello R.

Eur Radiol. 2008 Feb;18(2):234-43. Epub 2007 Oct 10.

PMID:
17929024

Supplemental Content

Loading ...
Support Center